Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers

AIDS

Volumn 27, Issue 17, 2013, Pages 2691-2696

  Asher, Alice K ^a,b   Santos, Glenn Milo ^b   Evans, Jennifer ^b   Dokubo, Emily K ^b   Lee, Tzong Hae ^c   Martin, Jeffrey N ^b   Deeks, Steven G ^b   Tobler, Leslie H ^c   Busch, Michael ^c   Hunt, Peter W ^b   Page, Kimberly ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

Hepatitis C virus; HIV control; Human leukocyte antigen type; Spontaneous clearance

Indexed keywords

HLA B57 ANTIGEN; INTERLEUKIN 28B;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ETHNICITY; FEMALE; GENDER; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS ELISA KIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RNA VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

ADULT; COHORT STUDIES; FEMALE; GENE FREQUENCY; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 84888304855     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000433242.86362.21     Document Type: Article

References (34)

1. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27:406-416.
2. Walker BD, Burton DR. Toward an AIDS Vaccine. Science 2008; 320:760-764.
3. Ruiz-Mateos E, Machmach K, Romero-Sanchez M, Ferrando-Martinez S, Viciana P, Del Val M, et al. Hepatitis C virus replication in Caucasian HIV controllers. J Viral Hepat 2011; 18:e350-e357.
4. Machmach K, Abad-Molina C, Romero-Sanchez MC, Abad MA, Ferrando-Martinez S, Genebat M, et al. IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects. J Infect Dis 2013; 207:651-655.
5. Sadaji M, Shakeri N, Talwani R, Redfield R. Hepatitis C infection in HIV-1 natural viral suppressors. AIDS 2010; 24:1689-1695.
6. Salgado M, Kirk G, Cox A, Rutebemberwa A, Higgins Y, Astemborski J, et al. Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors. AIDS 2011; 25:385-387.
7. Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, van Beek I, et al. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat 2007; 14:413-418.
8. Kloverpris HN, Stryhn A, Harndahl M, van der Stok M, Payne RP, Matthews PC, et al. HLA-BM57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. J Virol 2012; 86:919-929.
9. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al. HLA BM5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97:2709-2714.
10. Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, et al. HLA-B57/BM5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 2009; 83:2743-2755.
11. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, et al. HLA and HIV-1: heterozygote advantage and BM35-CwM04 disadvantage. Science 1999; 283:1748-1752.
12. Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. HLA-CwM04 and hepatitis C virus persistence. J Virol 2002; 76:4792-4797.
13. Balagopal A, Thomas DL, Thio CL. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010; 139:1865-1876.
14. Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 2010; 138:315-324.
15. van den Berg CH, Grady BP, Schinkel J, van de Laar T, MolenkampR, vanHoudt R, et al. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS One 2011; 6:e27555.
16. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, OHuigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
17. RauchA,Kutalik Z,Descombes P,Cai T, Di IulioJ,Mueller T, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study. Gastroenterology 2010; 138:1338-13451345 e1331-1337.
18. SajadiMM, Shakeri N, Talwani R, Howell CD, Pakyz R, Redfield RR, et al. IL28B genotype does not correlate with HIV control in African Americans. Clin Transl Sci 2011; 4:282-284.
19. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, et al. The major genetic determinants of HIV-1 control affect HLAclass I peptide presentation. Science 2010; 330:1551-1557.
20. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947.
21. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One 2008; 3:e3907.
22. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-BM57 alleles. PLoS One 2008; 3:e3636.
23. Parczewski M, Bander D, Leszczyszyn-Pynka M, Urbanska A, Socha L, Boron-Kaczmarska A. IL28B CC genotype is associated with higher all-cause mortality in antiretroviral-treated HIVinfected patients. AIDS Res Hum Retroviruses 2012; 28:1640-1646.
24. Hunt P, Hatano H, Sinclair E, Lee T, Busch M, Martin J, et al. HIV-specific CD4R T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis 2011; 52:681-687.
25. Gill RM, Lee TH, Utter GH, Reed WF, Wen L, Chafets D, et al. The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood 2008; 111:3880-3883.
26. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39:733-740.
27. Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, Duncan JE, et al. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 2006; 3:e492.
28. Matthews G, Dore G. HIV and hepatitis C coinfection. J Gastroenterol Hepatol 2008; 23:1000-1008.
29. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infectionsinshort-terminjectiondrugusers:theprevalenceofthe hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655-661.
30. Cotte L, Chevallier Queyron P, Schlienger I, Trabaud MA, Brochier C, Andre P, et al. Sexually transmitted HCV infection and reinfection in HIV-infected homosexual men. Gastroenterol Clin Biol 2009; 33:977-980.
31. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, et al. Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009; 200:1216-1226.
32. Grebely J, Page K, Sacks-Davis R, Schim van der Loeff M, Ric e TM, Bruneau J, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C Virus infection. Hepatology 2013; Aug 2 [Epub ahead of print]. doi: 10.1002/hep.26639.
33. Quinn PG, Jamal MM, Carey JD, Arora S, Harris T, Johnston DE, et al. A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia. Am J Gastroenterol 1999; 94:668-673.
34. Shores NJ, Maida I, Soriano V, Nunez M. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients. J Hepatol 2008; 49:323-328.